Related Experiment Video
Updated: Mar 7, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen1,2, Xi Feng2, Cameron J Herting1
1Department of Pediatrics and Aflac Cancer Center of Children's Health Care of Atlanta, Emory University School of Medicine, Atlanta, Georgia.
Abstract:
In glioblastoma (GBM), tumor-associated macrophages (TAM) represent up to one half of the cells of the tumor mass, including both infiltrating macrophages and resident brain microglia. In an effort to delineate the temporal and spatial dynamics of TAM composition during gliomagenesis, we used genetically engineered and GL261-induced mouse models in combination with CX3CR1GFP/WT;CCR2RFP/WT double knock-in mice. Using this approach, we demonstrated that CX3CR1LoCCR2Hi monocytes were recruited to the GBM, where they transitioned to CX3CR1HiCCR2Lo macrophages and CX3CR1HiCCR2- microglia-like cells. Infiltrating macrophages/monocytes constituted approximately 85% of the total TAM population, with resident microglia accounting for the approximately 15% remaining. Bone marrow-derived infiltrating macrophages/monocytes were recruited to the tumor early during GBM initiation, where they localized preferentially to perivascular areas. In contrast, resident microglia were localized mainly to peritumoral regions. RNA-sequencing analyses revealed differential gene expression patterns unique to infiltrating and resident cells, suggesting unique functions for each TAM population. Notably, limiting monocyte infiltration via genetic Ccl2 reduction prolonged the survival of tumor-bearing mice. Our findings illuminate the unique composition and functions of infiltrating and resident myeloid cells in GBM, establishing a rationale to target infiltrating cells in this neoplasm. Cancer Res; 77(9); 2266-78. ©2017 AACR.
Insights
Tumor-associated macrophages (TAM) in glioblastoma (GBM) include infiltrating monocytes and resident microglia. Targeting infiltrating monocytes, which are crucial for GBM growth, can improve survival.
Area of Science:
- Neuro-oncology
- Immunology
- Cell biology
Background:
- Tumor-associated macrophages (TAM) are key components of glioblastoma (GBM), comprising up to 50% of the tumor mass.
- Understanding the dynamic interplay between infiltrating macrophages and resident microglia in GBM is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the temporal and spatial dynamics of TAM composition during gliomagenesis.
- To differentiate the origins, localization, and functions of infiltrating macrophages versus resident microglia in GBM.
Main Methods:
- Utilized genetically engineered and GL261-induced mouse models.
- Employed CX3CR1GFP/WT;CCR2RFP/WT double knock-in mice for cell tracking.
- Performed RNA-sequencing to analyze gene expression patterns.
Main Results:
- Identified distinct monocyte (CX3CR1LoCCR2Hi) recruitment and subsequent transition to macrophages (CX3CR1HiCCR2Lo) and microglia-like cells (CX3CR1HiCCR2-) within GBM.
- Demonstrated that infiltrating bone marrow-derived macrophages constitute ~85% of TAM, localizing perivascularly, while resident microglia (~15%) are found in peritumoral regions.
- Showed that genetic reduction of CCL2, which limits monocyte infiltration, significantly prolonged survival in tumor-bearing mice.
Conclusions:
- Glioblastoma TAM populations are heterogeneously composed of distinct infiltrating and resident myeloid cells with unique functions.
- Infiltrating monocytes are critical for GBM progression, and targeting them offers a promising therapeutic strategy.

